Mga Batayang Estadistika
| CIK | 755806 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Poniard Pharmaceuticals, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 2, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2012 Date of Report (Date of earliest event reported) Poniard Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter) Washington 0-16614 91-1261311 (State or Other Jurisdiction of Incorporation) (C |
|
| April 2, 2012 |
Form 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16614 Poniard Pharmaceuticals, Inc. (Exact name of registrant as sp |
|
| March 30, 2012 |
Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 0-16614 NOTIFICATION OF LATE FILING CUSIP NUMBER 732449400 (Check one): þ Form 10-K ¨ Form 20F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2011 ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 1 |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 Post-Effective Amendment No. 1 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-71368) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name of registrant |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. TO FORM S-8 Post-Effective Amendment No. to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-126209) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name of |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-135861) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333- 41764) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333- 32583) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-89476) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name o |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 Post-Effective Amendment No. 1 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-143965) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name of registran |
|
| March 29, 2012 |
- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 29, 2012 Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (No. 333-115729) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC. (Exact name |
|
| March 23, 2012 |
Registration Withdrawal Poniard Pharmaceuticals, Inc. 300 Elliot Avenue West, Suite 530 Seattle, WA 98119 March 22, 2012 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mailstop 4631 Washington, D.C. 20549 Re: Poniard Pharmaceuticals, Inc. Registration Statement on Form S-4 File No. 333-175778 Ladies and Gentlemen: Poniard Pharmaceuticals, Inc., a D |
|
| March 22, 2012 |
- POST EFFECTIVE AMENDMENT NO. 2 TO FORM S-3 Post Effective Amendment No. 2 to Form S-3 As filed with the Securities and Exchange Commission on March 22, 2012 Post-Effective Amendment No. 2 to Registration Statements on Form S-3 (No. 333-159253) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post Effective Amendment No. 2 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PONIARD PHARMACEUTICALS, INC |
|
| January 5, 2012 |
Press Release Exhibit 99.1 Poniard Pharmaceuticals Common Stock to be Delisted from Nasdaq Stock Market, Intention to List on OTC Bulletin Board Ronald A. Martell Named Chairman of the Board, Steps Down as CEO Seattle, Wash. – January 3, 2012 – Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) announced today that the Nasdaq Hearings Panel has determined to delist the Company’s common stock from the Na |
|
| January 5, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 30, 2011 Date of Report (Date of earliest event reported) Poniard Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter) Washington 0-16614 91-1261311 (State or Other Jurisdiction of Incorporation) |
